May 24, 2018May 24, 2018

Brain Stimulation Done at Slower Rates May Be Best for MS and Other Patients as Neurons ‘Tire,’ Study Says

News

A non-invasive procedure using magnetic pulses to stimulate the brain may be more effective in treating multiple sclerosis (MS) and other patients if the rate of stimulation is ... Read more

May 24, 2018May 24, 2018

Gilenya Tied to Treatment Satisfaction, Quality of Life in MS Patients

News

Treatment with Gilenya (fingolimod) is associated with treatment satisfaction, which, in turn, is linked to a better quality-of-life in patients with relapsing-remitting multiple sclerosis (RRMS), a study ... Read more

May 23, 2018May 23, 2018

Subcutaneous Ofatumumab a Safe, Effective RRMS Therapy at Low Doses, Trial Results Show

News

A formulation of ofatumumab (brand name Arzerra) to be injected under the skin (subcutaneous) was found to be safe and effective in the treatment of relapsing-remitting ... Read more

May 23, 2018May 23, 2018

European EMA Confirms Severe Risks Associated with MS Medicine Zinbryta

News

A review of data concerning the multiple sclerosis (MS) medicine Zinbryta (daclizumab) confirmed its association with the risk of developing severe and potentially fatal immune reactions ... Read more

May 22, 2018May 22, 2018

Sativex Can Improve Driving Ability of MS Patients, Study Says

News

Sativex, a cannabis-based anti-spasticity medicine commercialized as oromucosal spray by GW Pharmaceuticals, improves the driving ability of patients with multiple sclerosis (MS), according to researchers. The ... Read more

May 22, 2018May 22, 2018

Thomas Jefferson University Opens Registry for Patients Using Medical Marijuana

News

The Lambert Center for the Study of Medicinal Cannabis and Hemp  has launched mmj.org, an initiative to advance the scientific community’s understanding of medical marijuana and its ... Read more

May 21, 2018May 21, 2018

Fat-Derived Stem Cells a Potential Safe, Feasible Treatment for Secondary Progressive MS, Trial Shows

News

Fat-derived stem cells are a safe and feasible treatment strategy for patients with secondary progressive multiple sclerosis, results from a Phase 1/2 clinical trial show. Findings ... Read more

May 21, 2018May 24, 2018

Gut Microbiome May Offer Way to Ease or Halt Brain Inflammation, Study Suggests

News

Metabolites produced by microbes in the gut can ease inflammation in the central nervous system by limiting the damage done by microglia, an immune cell of the ... Read more

May 18, 2018May 18, 2018

National MS Society Welcomes Mud-Lovers to 2018 MuckFest MS

News

The National Multiple Sclerosis Society is inviting all mud-lovers to Saturday’s kickoff of MuckFest MS in Boston, Massachusetts, which raises money and awareness for multiple sclerosis (MS). The ... Read more

May 18, 2018May 18, 2018

Rituximab Seen as Effective and Generally Safe RRMS and PMS Treatment in Study

News

Rituximab is generally safe and effective in treating multiple sclerosis — with comparable effectiveness to Tysabri (natalizumab) in people with relapsing-remitting forms of the disease, a ... Read more

May 17, 2018May 17, 2018

Impact of Early Aggressive vs. Standard Therapy on Disability in RRMS To Be Tested in Trial

News

A Johns Hopkins University-initiated clinical trial is starting to enroll an estimated 900 relapsing-remitting multiple sclerosis (RRMS) patients to assess the benefits of switching therapies to prevent ... Read more

May 17, 2018May 17, 2018

Viral Infection Promotes Factor in T-cells Leading to Brain Tissue Destruction

News

Infection with lymphocytic choriomeningitis virus triggers expression of a factor called TOX in immune cells strengthening their migration into the brain and promoting damaging effects, including ... Read more

May 16, 2018May 16, 2018

Complications from Gilenya Treatment Managed Successfully, Case Report Says

Alexa, News

A case study reported the successful management of a multiple sclerosis (MS) patient who developed a rare condition in the brain — progressive multifocal leukoencephalopathy (PML) — ... Read more

May 16, 2018May 16, 2018

4 Relapsing MS Treatments Added to UK Health Service After Cuts to Prices Agreed

News

After an agreement to lower their prices, four treatments for relapsing multiple sclerosis — Biogen’s Avonex and Merck KGaA‘s Rebif (both interferon beta-1a), Novartis’ Extavia (interferon beta 1b), and Teva’s ... Read more

May 15, 2018May 15, 2018

Gilenya Approved by FDA as First DMT for Children, Ages 10 and Older, with Relapsing MS

News

Gilenya (fingolimod) has become the first disease-modifying therapy approved by the U.S. Food and Drug Administration (FDA) to treat children and adolescents with relapsing forms of ... Read more

May 15, 2018May 15, 2018

#CMSC2018 – Julie Roberts, Country Music Singer and MS Advocate, Performing at CMSC Meeting

News

Julie Roberts, a country music singer and multiple sclerosis (MS) patient advocate, will perform at the upcoming Consortium of Multiple Sclerosis Centers (CMSC)’s annual meeting, the association announced ... Read more

May 14, 2018May 14, 2018

B-Cell Changes May Predict Conversion from Clinically Isolated Syndrome to MS, Study Suggests

News

B-cell alterations in peripheral blood may predict the conversion of clinically isolated syndrome (CIS) to multiple sclerosis (MS), a recent study suggests. Conducted in Turkey, the ... Read more

May 14, 2018May 14, 2018

Biomarker in Cerebrospinal Fluid Seen to Predict MS Progression in Study

News

A potential biomarker — the ratio of antibody proteins in cerebrospinal fluid at the time of diagnosis — was seen to predict which  multiple sclerosis patients will ... Read more